Pharmaceuticals Astellas Pharma Confirms FDA Approval of Zolbetuximab Resubmission Last updated: June 3, 2024 12:07 pm By bexib 0 Min Read Share SHARE The drug had been submitted previously but manufacturing issues necessitated a resubmission. You Might Also Like APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins New ways to determine drug value with health equity in mind Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer Share This Article Facebook Twitter Email Print Previous Article Yes, clicks and engagement affect SEO Next Article Alberta deer dealers team up as Horizon Ag & Turf – RealAgriculture Leave a comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Stay ConnectedFacebookLikeTwitterFollowYoutubeSubscribeTelegramFollowLatest News 30,000 people expected to attend Hong Kong FinTech Week in 2024 Fintech Indonesian crowdfunding platform Kitabisa enters the insurance field Fintech Linthwaite House launches new conference and special event packages Hospitality & Tourism Calculated risk: Thursday: CPI, unemployment claims Economy
